Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
SCOOP: White House backs impeaching ‘rogue’ judges accused...
House jams Senate by attaching repeal of Jack...
Poll shows which party has the edge ahead...
AOC accuses Trump of engaging in ‘increasingly erratic’...
Jack Smith says Trump ‘willfully’ broke the law,...
White House explains bruise on Trump’s hand
Convicted Minnesota fraudster alleges Walz, Ellison were aware...
Countries that signed Trump’s Gaza Board of Peace...
Trump admin stops funding for research that involves...
Jim Jordan says FBI searched Barron Trump’s room...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill

by admin December 6, 2025
December 6, 2025
Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill

A teenage girl who spent her final years advocating for young people battling cancer is forever memorialized in history, thanks to a key bill passed by the House of Representatives.

Mikaela Naylon was just 16 when she died five years after being diagnosed with osteosarcoma, a rare form of bone cancer.

Rep. Michael McCaul, R-Texas, who helped lead the landmark legislation that became her namesake, said Mikaela spent much of that time fighting to give fellow children a chance to survive cancer.

He told Fox News Digital that he viewed childhood cancer patients as ‘the best advocates’ for their cause, calling them his ‘better angels.’

‘Mikaela was a great example of that,’ McCaul said. ‘She was very sick. She’d just undergone radiation and chemotherapy. She wasn’t feeling very well, and I could tell. But she still made the effort to come to Washington, to go to members’ offices and advocate for the legislation.’

The Mikaela Naylon Give Kids A Chance Act is aimed at expanding children’s access to existing cancer therapy trials, as well as incentivizing development of treatments and solutions for pediatric cancer.

It reauthorizes funding for the National Institutes of Health (NIH) to support pediatric disease research through fiscal year 2027, and extends the Food and Drug Administration’s (FDA) ability to expedite review of drugs aimed at helping certain pediatric illnesses.

‘It’s probably one of the most rewarding things I’ve done is to not only draw awareness to childhood cancer by forming the [Childhood Cancer Caucus] and then having an annual summit, but to be able to pass legislation that results in saving children’s lives. I don’t think there’s anything more important than that,’ McCaul said.

His bill passed the House unanimously on Monday, with both Republicans and Democrats speaking out in strong support for the legislation.

Mikaela’s family was in attendance to watch both its passage and the speeches lawmakers gave in favor of it.

‘Nothing will take the place of her. But it helped fill kind of a void, an emptiness they have right now. And they’re very proud of that, that her legacy is carried on through this legislation,’ McCaul, who also gave the Naylon family a tour of the U.S. Capitol, said.

Mikaela’s parents Kassandra and Doug, and her brother Ayden, told Fox News Digital that she had ‘faced every day with hope, purpose and a fierce determination to make the world better for the kids who would come after her.’

‘She believed that all children, no matter how rare their diagnosis, deserve access to the most promising treatments and a real chance at life. This legislation reflects that mission,’ the Naylon family told Fox News Digital.

They thanked McCaul as well as Reps. Debbie Dingell, D-Mich., and Gus Bilirakis, R-Fla., for championing the bill, as well as advocacy groups who also helped shepherd it forward.

‘Their commitment ensures that Mikaela‘s voice, and the voices of so many brave children like her, will forever be heard in the halls of Congress,’ the family said.

This post appeared first on FOX NEWS

previous post
State-level AI rules survive — for now — as Senate sinks moratorium despite White House pressure
next post
Trump signs off on nationwide vaccine schedule review as CDC withdraws infant hep B guidance: ‘Fast track’

You may also like

Donald Trump fires National Portrait Gallery director for...

May 31, 2025

Israel bans UN secretary-general over anti-Israel actions: ‘Doesn’t...

October 3, 2024

WATCH: GOP senators rail against staggering $4.7 trillion...

May 24, 2025

As GOP political power hangs in the balance,...

December 9, 2025

State Department stays quiet as Albania reinstates deputy...

December 14, 2025

Reporter’s Notebook: Eyewitness to Taiwan’s annual military drills...

July 30, 2024

FBI Deputy Director Dan Bongino: James Comey ‘brought...

May 18, 2025

8 House Dems demand to know how social...

October 4, 2024

Vice President JD Vance to play key role...

March 18, 2025

JD Vance skips Trump’s Venezuela spotlight, but aide...

January 3, 2026

Recent Posts

  • SCOOP: White House backs impeaching ‘rogue’ judges accused of partisan rulings
  • House jams Senate by attaching repeal of Jack Smith provision to $1.2T funding package
  • Poll shows which party has the edge ahead of midterm elections for Congress
  • AOC accuses Trump of engaging in ‘increasingly erratic’ behavior
  • Jack Smith says Trump ‘willfully’ broke the law, blasts DOJ ‘retribution’ in second term

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (967)
    • Investing (3,933)
    • Politics (4,750)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.